This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Allen KA. Hypoxic Ischemic Encephalopathy: Pathophysiology Experimental Treatments. 2012;11(3):125–33.AllenKA20121131253310.1053/j.nainr.2011.07.004Search in Google Scholar
Edwards AB, Anderton RS, Knuckey NW, Meloni BP. Perinatal hypoxic-ischemic encephalopathy and neuroprotective peptide therapies: A case for cationic arginine-rich peptides (CARPs). Brain Sci. 2018;8(8):15–20.EdwardsABAndertonRSKnuckeyNWMeloniBPPerinatal hypoxic-ischemic encephalopathy and neuroprotective peptide therapies: A case for cationic arginine-rich peptides (CARPs)2018881510.3390/brainsci8080147Search in Google Scholar
Frajewicki A, Laštůvka Z, Borbélyová V, Khan S, Jandová K, Janišová K, et al. Perinatal hypoxic-ischemic damage: review of the current treatment possibilities. Physiol Res. 2021;69:S379–401.FrajewickiALaštůvkaZBorbélyováVKhanSJandováKJanišováKPerinatal hypoxic-ischemic damage: review of the current treatment possibilities202169S37940110.33549/physiolres.934595Search in Google Scholar
Heiss EH, Schachner D, Zimmermann K, Dirsch VM. Glucose availability is a decisive factor for Nrf2-mediated gene expression. Redox Biol. 2013;1(1):359–65.HeissEHSchachnerDZimmermannKDirschVMGlucose availability is a decisive factor for Nrf2-mediated gene expression20131135910.1016/j.redox.2013.06.001Search in Google Scholar
Kubo E, Chhunchha B, Singh P, Sasaki H, Singh DP. Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress. Sci Rep. 2017;7(1):1–17.KuboEChhunchhaBSinghPSasakiHSinghDPSulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress201771110.1038/s41598-017-14520-8Search in Google Scholar
Dang J, Brandenburg LO, Rosen C, Fragoulis A, Kipp M, Pufe T, et al. Nrf2 expression by neurons, astroglia, and microglia in the cerebral cortical penumbra of ischemic rats. J Mol Neurosci. 2012;46(3):578–84.DangJBrandenburgLORosenCFragoulisAKippMPufeTNrf2 expression by neurons, astroglia, and microglia in the cerebral cortical penumbra of ischemic rats201246357810.1007/s12031-011-9645-9Search in Google Scholar
Liu L, Locascio LM, Doré S. Critical Role of Nrf2 in Experimental Ischemic Stroke. Front Pharmacol. 2019; 10:153LiuLLocascioLMDoréSCritical Role of Nrf2 in Experimental Ischemic Stroke20191015310.3389/fphar.2019.00153Search in Google Scholar
Vannucci RC, Vannucci SJ. Perinatal hypoxic-ischemic brain damage: Evolution of an animal model. Developmental Neuroscience. 2005.VannucciRCVannucciSJPerinatal hypoxic-ischemic brain damage: Evolution of an animal model200510.1159/000085978Search in Google Scholar
Sánchez F, Orero A, Soriano A. ALBIRA : A small animal PET / SPECT / CT imaging system. 2013;40(5):1–11.SánchezFOreroASorianoA201340511110.1118/1.4800798Search in Google Scholar
Huang BY, Castillo M. Hypoxic-Ischemic brain injury: Imaging findings from birth to adulthood. Radiographics. 2008;28(2):417–39.HuangBYCastilloMHypoxic-Ischemic brain injury: Imaging findings from birth to adulthood200828241710.1148/rg.282075066Search in Google Scholar
Danilov CA, Chandrasekaran K, Racz J, Soane L, Zielke C, Fiskum G. Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia. 2009; 57(6): 645–656.DanilovCAChandrasekaranKRaczJSoaneLZielkeCFiskumGSulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation200957664565610.1002/glia.20793Search in Google Scholar
Giacoppo S, Galuppo M, Montaut S, Iori R, Rollin P, Bramanti P, et al. An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases. Fitoterapia. 2015;106:12–21.GiacoppoSGaluppoMMontautSIoriRRollinPBramantiPAn overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases2015106122110.1016/j.fitote.2015.08.001Search in Google Scholar
Tarozzi A, Angeloni C, Malaguti M, Morroni F, Hrelia S, Hrelia P. Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid Med Cell Longev. 2013;2013: 415078.TarozziAAngeloniCMalagutiMMorroniFHreliaSHreliaPSulforaphane as a potential protective phytochemical against neurodegenerative diseases2013201341507810.1155/2013/415078Search in Google Scholar
Guerrero-Beltrán CE, Calderón-Oliver M, Pedraza-Chaverri J, Chirino YI. Protective effect of sulforaphane against oxidative stress: Recent advances. Exp Toxicol Pathol. 2012;64(5):503–8.Guerrero-BeltránCECalderón-OliverMPedraza-ChaverriJChirinoYIProtective effect of sulforaphane against oxidative stress: Recent advances201264550310.1016/j.etp.2010.11.005Search in Google Scholar
Narayanaswami V, Dahl K, Bernard-Gauthier V, Josephson L, Cumming P, Vasdev N. Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: Outlook Beyond TSPO. Mol Imaging. 2018;17:1–25.NarayanaswamiVDahlKBernard-GauthierVJosephsonLCummingPVasdevNEmerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: Outlook Beyond TSPO20181712510.1177/1536012118792317Search in Google Scholar
Svoboda J, Litvinec A, Kala D, Pošusta A, Vávrová L, Jiruška P, et al. Strain differences in intraluminal thread model of middle cerebral artery occlusion in rats. Physiol Res. 2019;68(1):37–48.SvobodaJLitvinecAKalaDPošustaAVávrováLJiruškaPStrain differences in intraluminal thread model of middle cerebral artery occlusion in rats20196813710.33549/physiolres.933958Search in Google Scholar